PsyBio Therapeutics Corp.
PSYBF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $2,952 | $17,110 | $9,526 | $710 |
| - Cash | $1 | $124 | $270 | $162 |
| + Debt | $135 | $0 | $0 | $0 |
| Enterprise Value | $3,086 | $16,985 | $9,256 | $549 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$50 | -$1,563 | -$1,535 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,526 | -$9,579 | $0 | $156 |
| % Margin | – | – | – | – |
| Net Income | -$4,886 | -$11,019 | -$6,436 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.042 | -0.1 | -0.2 | 0 |
| % Growth | 58% | 50% | – | – |
| Operating Cash Flow | -$3,437 | -$6,950 | -$864 | -$24 |
| Capital Expenditures | $0 | $4 | $0 | $0 |
| Free Cash Flow | -$3,437 | -$6,946 | -$864 | -$24 |